PRŮBĚŽNÁ ZPRÁVA O PRŮBĚHU STUDIE V ČR - SIOP Ependymoma II - An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with Ependymoma
| Title in English | INTERIM REPORT ON THE COURSE OF STUDIES IN THE CZECH REPUBLIC - SIOP Ependymoma II - An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with Ependymoma |
|---|---|
| Authors | |
| Year of publication | 2021 |
| MU Faculty or unit | |
| Web | SIOP |
| Description | Submission of the Annual Report on the course of the clinical trial of SIOP Ependymoma II for the period from 14 October 2020 to 14 October 2021. SIOP Ependymoma II is an international clinical program for the diagnosis and treatment of children, adolescents and young adults with ependymoma. SÚKL granted a permit for KH on 23 February 2017, and a total of 614 patients were included in the study worldwide (data from 9 November 2021). The clinical trial is taking place in the Czech Republic at The University Hospital Brno (8 patients so far) and at the Motol University Hospital in Prague (2 patients included so far). The new version of the protocol for clinical trials (version 3.1.) was approved by SÚKL on 1 October 2020. |
| Related projects: |